Abstract:Objective We aimed to investigate the yield of prenatal exome sequencing (pES) in morphologically normal fetuses. Method This retrospective study analyzed 254 families with morphologically normal fetuses who underwent prenatal trio exome sequencing based on parental request between September 2020 and October 2023. Results Overall, abnormal findings were detected in 8 families (3.1%, 8/254) by pES. Among these, 6 families (2.3%, 6/254) were found to have fetuses affected with monogenic disorders (2 autosomal recessive conditions and 4 autosomal dominant conditions), while 2 families (0.8%, 2/254) were incidentally found to be couples at risk of having a future pregnancy with a recessive condition. Among the six fetuses detected with monogenic disorders, two fetuses carried a de novo variant in OPA1 and NF1, which are known to cause Optic atrophy 1 and Neurofibromatosis, respectively. One fetus was detected with a maternally inherited variant in PKD2 related to polycystic kidney disease 2 (not known to the mother until then). One fetus was detected with a maternally inherited variant in SDHB associated with Pheochromocytoma. Two fetuses carried compound heterozygous variants in NAGLU and GJB2 associated with Mucopolysaccharidosis type IIIB and Deafness, respectively. In the 2 families where parents were found to be carriers but the fetuses were unaffected, heterozygous variants in the GJB2 and SERPINB7 genes were detected in the parents, respectively, which are associated with deafness and palmoplantar keratoderma. Conclusion Our research indicated that pES can provide significant critical information for families with morphologically normal fetuses. Prenatal screening with exome sequencing requires careful management and detailed pre‐test and post‐test genetic counseling.

Low-level parental somatic mosaic SNVs in exomes from a large cohort of trios with diverse suspected Mendelian conditions

Parental Mosaicism Detection and Preimplantation Genetic Testing in Families with Multiple Transmissions of De Novo Mutations.

Low-level germline mosaicism of a novel <i>SMARCA2</i> missense variant: Expanding the phenotypic spectrum and mode of genetic transmission

Clinically-relevant postzygotic mosaicism in parents and children with developmental disorders in trio exome sequencing data

Somatic mosaicism detected by genome-wide sequencing in 500 parent-child trios with suspected genetic disease: clinical and genetic counseling implications

Identification of of a <i>PAX2</i> mutation from maternal mosaicism causes recurrent renal disorder in siblings

Case Report: Identification of Maternal Low-Level Mosaicism in the Dystrophin Gene by Droplet Digital Polymerase Chain Reaction

Quantitative assessment of low-level parental mosaicism of SNVs and CNVs in Waardenburg syndrome

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

High positive predictive value of CNVs detected by clinical exome sequencing in suspected genetic diseases

Postzygotic Single-Nucleotide Mosaicisms in Whole-Genome Sequences of Clinically Unremarkable Individuals.

Parental Somatic Mosaicism Detected During Prenatal Diagnosis

Paternal Low-Level Mosaicism-Caused SATB2-Associated Syndrome

Uncovering recessive alleles in rare Mendelian disorders by genome sequencing of 174 individuals with monoallelic pathogenic variants

Prenatal Diagnosis by Trio Clinical Exome Sequencing: Single Center Experience

Narrowing the Diagnostic Gap: Genomes, Episignatures, Long-Read Sequencing and Health Economic Analyses in an Exome-Negative Intellectual Disability Cohort

Patterns and rates of exonic de novo mutations in autism spectrum disorders

Comprehensive identification of somatic nucleotide variants in human brain tissue

Mosaic chromosomal alterations in blood across ancestries using whole-genome sequencing

MosaicHunter: Accurate Detection of Postzygotic Single-Nucleotide Mosaicism Through Next-Generation Sequencing of Unpaired, Trio, and Paired Samples

Prenatal exome sequencing for morphologically normal fetus: Should we be doing it?